navbar brand navbar brand
  • Course Catalog
  • Event Calendar
  • Contact Us

You are being redirected to another site.


Back to Post List
New Post
Title(*)
Description
  • Introduction
Click on the on the top progress bar to review the step.
4th Pan American Parkinson's Disease and Movement Disorders Congress Plenary Sessions
Course Format
Regional Online Course
Release Date
June 22, 2022
Expiration Date
June 29, 2023
...
Program Description

The MDS-4th Pan American Parkinson’s Disease and Movement Disorders Congress Plenary Sessions provides participants with access to six recorded Plenary Sessions that took place at the PAS Congress from May 26-28, 2022 in Miami, FL, USA. The topics covered in the six sessions include Diagnosis of Parkinson's Disease, Tremor, Treatment of Parkinson's Disease, Equity of Care - Underrepresented Populations in the Americas, Controversies in Movement Disorders, and Hot Topics in Movement Disorders: The Pan American Perspective. 

Course Purpose

The MDS-4th Pan American Parkinson’s Disease and Movement Disorders Congress Plenary Sessions are to provide participants with access to six recorded Plenary Sessions from the 2022 PAS Congress and access to the booklet of abstracts.


Member Rate: $50

No Fee Member: $30

Non-Member Rate: $100

Students/Fellows & Residents: FREE


Learning Objectives

Upon completion of this activity, learners will be able to:

1. Identify the pathophysiology and microbiology of Parkinson’s disease and other movement disorders.

2. Appraise diagnostic approaches for management of Parkinson’s disease and other movement disorders.

3. Evaluate pharmacological and non-pharmacological treatment options available for Parkinson’s disease and other  movement disorders.

Intended Audience

This activity is intended for clinicians, researchers, post-doctoral fellows, medical residents, medical students, allied health professionals with an interest in current clinical trends and approaches for diagnosis and treatment of movement disorders.

Method of Participation

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

Faculty Disclosure

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available HERE. All relevant financial relationships have been mitigated in advance of this program.

Accreditation and Credit Designation

Accreditation Statement: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation Statement:

The International Parkinson and Movement Disorder Society designates this activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

Hardware and Software Requirement

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate. 

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Contact Us
MDS Education
education@movementdisorders.org
Available Lectures

Plenary Session 1: Diagnosis of Parkinson's Disease

  1. Diagnostic Biomarkers's for Prodromal or Early Parkinson's Disease | Lorraine Kaila
  2. Definition of Early-Onset Parkinson's Disease | Roy Alcalay
  3. Diagnosis of Parkinson's Disease Subtypes | Connie Marras


Plenary Session 2: Tremor

  1. The Cerebellum in Essential Tremor: Primary Driver or Innocent Bystander? | Sheng-Han Kuo
  2. Emerging Medical Therapies for Essential Tremor… Hope or Hype? | William Ondo
  3. Diagnosis and Treatment of Dystonic Tremor, Vocal Tremor and Task-Specific Tremor… Controversy or Much Ado About Nothing? | Aasef Shaikh


Plenary Session 3: Treatment of Parkinson's Disease

  1. Current Medical Treatments for Parkinson’s Disease Across the Americas | Henrique Ferraz
  2. Future Medical Treatment of Parkinson’s Disease |Tiago Mestre
  3. Current and Future Surgical Treatments of Parkinson’s Disease | Helen Bronte-Stewart


Plenary Session 4: Equity of Care - Underrepresented Populations in the Americas

  1. Race, Ethnicity and Gender in Parkinson’s Disease | Allison Willis
  2. Reaching Underserved Populations in Parkinson’s Disease in North America | Britt Stone
  3. Reaching Underserved Populations in Parkinson’s Disease in Latin America | Mayela Rodriguez Violante


Plenary Session 5: Controversies in Movement Disorders

  1. Are we Close to a Cure for Huntington’s Disease? | Cristina Sampaio, Emailia Gatto
  2. Can iPSC-Derived Models Replace Animal Models of Movement Disorders? | Birgitt Schuele, Serge Przedborski
  3. Can Telemedicine Replace Traditional Medicine for Movement Disorders? | E. Ray Dorsey, Anthony Lang


Plenary Session 6: Hot Topics in Movement Disorders: The Pan-American Perspective

  1. Past, Present and Future: Impact of COVID-19 on Parkinson’s Disease and Movement Disorders | Marcelo Merello
  2. “Social Prescribing”: Mental and Physical Wellbeing in Parkinson’s Disease | Indu Subramanian
  3. Why is our Approach Not Working in Disease Modification in Atypical Parkinsonisms | Irene Litvan

Copyright © 1998-2023 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved.

Processing...
×